Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: Endo (Keenova Therapeutics and Par Health) (endo.com)
Endo.com currently functions as a ‘ghost ship’ transition portal that offers high-level corporate narrative but zero pharmaceutical substance. It serves as a navigational bridge following a merger, which explains the high BS score regarding actual proof and identity, as the substance has been migrated to child domains. The presence of ‘reviews’ on a privacy page is a definitive technical red flag for trust-theatre leakage.
Medical Devices, Pharma & Biotech Reputation: Endo (Keenova Therapeutics and Par Health) (endo.com)
The site content strongly aligns with the Pharma and Biotech industry, specifically referencing therapeutic areas like immunology and urology, as well as pharmaceutical components like APIs and sterile injectables. It correctly uses industry-specific terminology regarding mergers, spinoffs, and regulatory compliance within a therapeutic context.
“The score of 48 is driven primarily by the lack of technical authority (Step 5) and the absence of verifiable proof (Step 3). While the information is coherent regarding the merger (Step 2), it fails to provide the density of data required to move from 'Marketing Signal' to 'Substance'. The presence of trust theatre flags on non-reviewable pages significantly penalized the Trust and Proof pillar.”